drugset / Trial / NCT03868540
A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 1291583 in healthy male and female subjects following oral administration of multiple rising doses over 4 weeks.
Timeline
- Start
- 2019-03-28
- Primary completion
- 2019-11-25
- Completion
- 2019-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1291583 | Unknown | — | Oral |
Indications
No indication recorded.